Search Results - "FERRARI, Guido"
-
1
Curing HIV: Seeking to Target and Clear Persistent Infection
Published in Cell (02-04-2020)“…Human immunodeficiency virus type 1 (HIV-1) infection persists despite years of antiretroviral therapy (ART). To remove the stigma and burden of chronic…”
Get full text
Journal Article -
2
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Published in The New England journal of medicine (05-04-2012)“…This analysis of correlates of the risk of HIV-1 infection in the RV144 vaccine trial identifies hypotheses for improving efficacy. The data indicate key roles…”
Get full text
Journal Article -
3
Single-Cell Analysis of Quiescent HIV Infection Reveals Host Transcriptional Profiles that Regulate Proviral Latency
Published in Cell reports (Cambridge) (02-10-2018)“…A detailed understanding of the mechanisms that establish or maintain the latent reservoir of HIV will guide approaches to eliminate persistent infection. We…”
Get full text
Journal Article -
4
Sustainable Tourism Destinations
Published in Journal of hospitality & tourism research (Washington, D.C.) (01-09-2022)Get full text
Journal Article -
5
Interaction with Cellular CD4 Exposes HIV-1 Envelope Epitopes Targeted by Antibody-Dependent Cell-Mediated Cytotoxicity
Published in Journal of Virology (01-03-2014)“…Classifications Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
6
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
Published in Proceedings of the National Academy of Sciences - PNAS (28-05-2013)“…Analysis of correlates of risk of infection in the RV144 HIV-1 vaccine efficacy trial demonstrated that plasma IgG against the HIV-1 envelope (Env) variable…”
Get full text
Journal Article -
7
Hinge length contributes to the phagocytic activity of HIV-specific IgG1 and IgG3 antibodies
Published in PLoS pathogens (24-02-2020)“…Antibody functions such as neutralization require recognition of antigen by the Fab region, while effector functions are additionally mediated by interactions…”
Get full text
Journal Article -
8
An HIV-1 gp120 Envelope Human Monoclonal Antibody That Recognizes a C1 Conformational Epitope Mediates Potent Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity and Defines a Common ADCC Epitope in Human HIV-1 Serum
Published in Journal of Virology (01-07-2011)“…OA Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+…”
Get full text
Journal Article -
9
A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1
Published in eLife (15-04-2024)“…A productive HIV-1 infection in humans is often established by transmission and propagation of a single transmitted/founder (T/F) virus, which then evolves…”
Get full text
Journal Article -
10
Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIVmac251 Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial
Published in Journal of Virology (01-02-2013)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
11
Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection
Published in Journal of Virology (01-10-2011)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
12
High antibody-dependent cellular cytotoxicity responses are correlated with strong CD8 T cell viral suppressive activity but not with B57 status in HIV-1 elite controllers
Published in PloS one (23-09-2013)“…The role of Antibody-dependent cellular cytotoxicity (ADCC) responses in HIV-1 controllers is still unclear due to the heterogeneity of these patients. We…”
Get full text
Journal Article -
13
A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies
Published in Journal of virology (15-02-2016)“…Previous studies have shown that sera from HIV-1-infected individuals contain antibodies able to mediate antibody-dependent cellular cytotoxicity (ADCC). These…”
Get full text
Journal Article -
14
Innate immune signatures to a partially-efficacious HIV vaccine predict correlates of HIV-1 infection risk
Published in PLoS pathogens (15-03-2021)“…The pox-protein regimen tested in the RV144 trial is the only vaccine strategy demonstrated to prevent HIV-1 infection. Subsequent analyses identified antibody…”
Get full text
Journal Article -
15
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
Published in PLoS pathogens (20-06-2024)“…Antibodies perform both neutralizing and non-neutralizing effector functions that protect against certain pathogen-induced diseases. A human antibody directed…”
Get full text
Journal Article -
16
Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1
Published in Frontiers in immunology (10-05-2019)“…It is now well-accepted that Fc-mediated effector functions, including antibody-dependent cellular cytotoxicity (ADCC), can contribute to vaccine-elicited…”
Get full text
Journal Article -
17
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
Published in Molecular therapy. Nucleic acids (15-04-2019)“…Despite the enormous effort in the development of effective vaccines against HIV-1, no vaccine candidate has elicited broadly neutralizing antibodies in…”
Get full text
Journal Article -
18
Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A Phase 1/2a HIV-1 Vaccine Trial
Published in Journal of acquired immune deficiency syndromes (1999) (01-08-2024)“…An effective vaccine is required to end the HIV pandemic. We evaluated the safety and immunogenicity of a DNA (DNA-HIV-PT123) vaccine with low- or high-dose…”
Get full text
Journal Article -
19
Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models
Published in Journal of virology (15-05-2019)“…Studies in animal models are essential prerequisites for clinical trials of candidate HIV vaccines. Small animals, such as rabbits, are used to evaluate…”
Get full text
Journal Article -
20
FlowKit: A Python Toolkit for Integrated Manual and Automated Cytometry Analysis Workflows
Published in Frontiers in immunology (05-11-2021)“…An important challenge for primary or secondary analysis of cytometry data is how to facilitate productive collaboration between domain and quantitative…”
Get full text
Journal Article